Intra-Arterial Chemo Promising for Intraocular Retinoblastoma

This article originally appeared here.
Share this content:
Intra-Arterial Chemo Promising for Intraocular Retinoblastoma
Intra-Arterial Chemo Promising for Intraocular Retinoblastoma

MONDAY, March 21, 2016 (HealthDay News) -- Intra-arterial chemotherapy appears to be promising for intraocular retinoblastoma, according to a review published online March 17 in JAMA Ophthalmology.

Yacoub A. Yousef, M.D., from the Hospital for Sick Children in Toronto, and colleagues conducted a systematic review to summarize the outcomes of intra-arterial chemotherapy. Data were included from 12 publications with discernable nonduplicative information, reporting on 655 patients, 757 eyes, and 2,350 catheterizations.

The researchers found that all reports were single-arm case series, and eight were retrospective. Global salvage was achieved for 66 percent of all eyes across all studies. Chorioretinal atrophy and vascular occlusions were the most common reported toxicities. There were reports of at least 13 children with metastases; seven additional children had metastases after publication. Comparison of disease severity at presentation was complicated by use of four different classification systems. In most studies, visual outcome was not addressed; no study had a comparative group and consequently meta-analysis was not possible

"Intra-arterial chemotherapy is a promising new treatment associated with high rates of globe salvage," the authors write. "However, the literature is limited by the predominance of retrospective case series, absence of comparison groups, short median follow-up, heterogeneous definitions and tumor classifications, and frequent duplicate reporting."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC Concerned About Falling Flu Vaccination Rates

CDC Concerned About Falling Flu Vaccination Rates

Decline among vulnerable older adults is of particular concern

One in Five With Non-Valvular A-Fib Receiving Digoxin

One in Five With Non-Valvular A-Fib Receiving Digoxin

Indication for digoxin use was considered inappropriate in 59.8 percent in Turkish cohort

Rapid, Successful Response to ART for Many Patients With HIV

Rapid, Successful Response to ART for Many Patients ...

Factors associated with virological success include having undetectable viral load, use of three drugs

is free, fast, and customized just for you!

Already a member?

Sign In Now »